Jens Harborth

15.6k total citations · 2 hit papers
24 papers, 9.9k citations indexed

About

Jens Harborth is a scholar working on Molecular Biology, Cell Biology and Genetics. According to data from OpenAlex, Jens Harborth has authored 24 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 7 papers in Cell Biology and 3 papers in Genetics. Recurrent topics in Jens Harborth's work include RNA Research and Splicing (7 papers), Microtubule and mitosis dynamics (6 papers) and RNA Interference and Gene Delivery (5 papers). Jens Harborth is often cited by papers focused on RNA Research and Splicing (7 papers), Microtubule and mitosis dynamics (6 papers) and RNA Interference and Gene Delivery (5 papers). Jens Harborth collaborates with scholars based in Germany, United States and Netherlands. Jens Harborth's co-authors include Klaus Weber, Sayda M. Elbashir, Thomas Tuschl, Abdullah Yalçın, Mary Osborn, Stephen A. Scaringe, Ernst Ungewickell, Johannes Fruehauf, Thu Anh Nguyen and Anton Karabinoš and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jens Harborth

24 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

2001 7.6k citations Sayda M. Elbashir, Jens Harborth et al. Nature profile →
Identification of essential genes in cultured mammalian cells using small interfering RNAs

2001 700 citations Jens Harborth, Sayda M. Elbashir et al. Journal of Cell Science profile →

Peers

Countries citing papers authored by Jens Harborth

Since Specialization

Citations

This map shows the geographic impact of Jens Harborth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Harborth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Harborth more than expected).

Fields of papers citing papers by Jens Harborth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Harborth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Harborth. The network helps show where Jens Harborth may publish in the future.

Co-authorship network of co-authors of Jens Harborth

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Harborth. A scholar is included among the top collaborators of Jens Harborth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Harborth. Jens Harborth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Novel Lipid Nanoparticle NBF-006 Encapsulating Glutathione S-Transferase P siRNA for the Treatment of KRAS-Driven Non–small Cell Lung Cancer 2024 ·Molecular Cancer Therapeutics ·(unknown), Bharat K. Majeti, Zhihong O’Brien, (unknown), (unknown), Roger Adami, (unknown), Jens Harborth, Wenbin Ying, Sonya Zabludoff	3
2	Abstract 5917: A novel lipid nanoparticle (NBF-006) encapsulating glutathione S-transferase P (GSTP) siRNA for the treatment of KRAS-driven non-small cell lung cancer 2018 ·Cancer Research ·Zhihong O’Brien, (unknown), Bharat K. Majeti, Jean‐Pierre Clamme, (unknown), (unknown), (unknown), Jens Harborth, (unknown), Haiqing Yin, Jing Yu, (unknown), Roger Adami, Sonya Zabludoff, Wenbin Ying	18
3	565 Ind-Enabling Studies for CEQ508 Targeting β-Catenin of GI Polyps: First Oral RNAI Drug 2010 ·Gastroenterology ·Natalya D. Bodyak, (unknown), Johannes Fruehauf, Jens Harborth, Moreshwar B. Vaze, Catherine Grillot‐Courvalin, (unknown)	1
4	Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV) 2008 ·Antiviral Research ·John P. DeVincenzo, Jeff Cehelsky, Rene Alvarez, Sayda M. Elbashir, Jens Harborth, Iva Toudjarska, Lubomir V. Nechev, (unknown), (unknown), Akshay Vaishnaw	197
5	RNAi therapeutics: an update on delivery. 2008 ·PubMed ·Thu Anh Nguyen, (unknown), Jens Harborth, Johannes Fruehauf	86
6	Nucleoplasmic LAP2α–lamin A complexes are required to maintain a proliferative state in human fibroblasts 2007 ·The Journal of Cell Biology ·Vanja Pekovic‐Vaughan, Jens Harborth, Jos L. V. Broers, Frans C. S. Ramaekers, Baziel G.M. van Engelen, Martin Lammens, Thomas von Zglinicki, Roland Foisner, Chris Hutchison, Ewa Markiewicz	109
7	RNA Interference-based Strategies for Metabolic Syndrome Treatment 2005 ·Hormone and Metabolic Research ·A. Barthel, Stephan Herzig, H. W. Müller, Jens Harborth, Stefan R. Bornstein	3
8	Sequence, Chemical, and Structural Variation of Small Interfering RNAs and Short Hairpin RNAs and the Effect on Mammalian Gene Silencing 2003 ·Antisense and Nucleic Acid Drug Development ·Jens Harborth, Sayda M. Elbashir, (unknown), (unknown), Stephen A. Scaringe, Klaus Weber, Thomas Tuschl	372
9	Analysis of mammalian gene function using small interfering RNAs 2003 ·Nucleic Acids Symposium Series ·Javier Martı̂nez, (unknown), Sayda M. Elbashir, Jens Harborth, Markus Hoßbach, Henning Urlaub, Julia Meyer, K. Weber, Kimberlie Vandenburgh, (unknown), Stephen A. Scaringe, (unknown), (unknown)	11
10	Effect of Clathrin Heavy Chain- and α-Adaptin-specific Small Inhibitory RNAs on Endocytic Accessory Proteins and Receptor Trafficking in HeLa Cells 2003 ·Journal of Biological Chemistry ·(unknown), Jens Harborth, (unknown), Klaus Weber, Ernst Ungewickell	223
11	Effects of expressing lamin A mutant protein causing Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy in Hela cells 2003 ·Experimental Cell Research ·(unknown), Mariana Lagos‐Quintana, Jens Harborth, Klaus Weber, Mary Osborn	40
12	The mitotic-spindle-associated protein astrin is essential for progression through mitosis 2002 ·Journal of Cell Science ·Jens Gruber, Jens Harborth, (unknown), Klaus Weber, Meçhthild Hatzfeld	72
13	Essential roles for four cytoplasmic intermediate filament proteins in Caenorhabditis elegans development 2001 ·Proceedings of the National Academy of Sciences ·Anton Karabinoš, Henning Schmidt, Jens Harborth, Ralf Schnabel, Klaus Weber	101
14	Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells breakdown → 2001 ·Nature ·Sayda M. Elbashir, Jens Harborth, (unknown), Abdullah Yalçın, Klaus Weber, Thomas Tuschl	7595
15	GAS41, a Highly Conserved Protein in Eukaryotic Nuclei, Binds to NuMA 2000 ·Journal of Biological Chemistry ·Jens Harborth, Klaus Weber, Mary Osborn	39
16	Self assembly of NuMA: multiarm oligomers as structural units of a nuclear lattice 1999 ·The EMBO Journal ·Jens Harborth	96
17	Does NuMA Have a Scaffold Function in the Interphase Nucleus? 1999 ·Critical Reviews in Eukaryotic Gene Expression ·Jens Harborth, Mary Osborn	13
18	Induction of a Regular Nuclear Lattice by Overexpression of NuMA 1998 ·Experimental Cell Research ·Catherine Gueth-Hallonet, Jian Wang, Jens Harborth, Klaus Weber, Mary Osborn	64
19	New monoclonal antibodies recognizing phosphorylated proteins in mitotic cells 1995 ·Acta Histochemica ·(unknown), Jens Harborth, Mary Osborn, Uwe Karsten	5
20	Microinjection of a monoclonal antibody against SPN antigen, now identified by peptide sequences as the NuMA protein, induces micronuclei in PtK2 cells 1993 ·Journal of Cell Science ·Markku Kallajoki, Jens Harborth, Klaus Weber, Mary Osborn	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact